InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by SOUTHWELL DAVID P, Chief Executive Officer. Insider active across 2 companies, notably TScan Therapeutics, Inc.. Cumulatively, 7 filings have been recorded. Total volume traded: €214k. The latest transaction was disclosed on 18 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
€51,88615,000 shares@ €3.45910.079% mcap13.5% of flow
Voting Common Stock
SEC:0000899243-22-019018:0·
Ideal exit: 12 Feb 2023 (T+270)
03,200 shares0
Common Stock
SEC:0001179110-22-000384·
03,200 shares0
Common Stock
SEC:0001179110-22-000384:0·
€84,63348,670 shares@ €1.73890.13% mcap51.0% of flow
Voting Common Stock
SEC:0000899243-21-049764·
€84,63348,670 shares@ €1.73890.13% mcap22.1% of flow
Voting Common Stock
SEC:0000899243-21-049764:0·
€81,28111,000 shares@ €7.38910.12% mcap49.0% of flow
Voting Common Stock
SEC:0000899243-21-035442·
Ideal exit: 5 Jun 2022 (T+270)
€81,28111,000 shares@ €7.38910.12% mcap21.2% of flow
Voting Common Stock
SEC:0000899243-21-035442:0·
Ideal exit: 5 Jun 2022 (T+270)
7 of 7 declarations
About SOUTHWELL DAVID P
David P. Southwell is the Chief Executive Officer and Board Member at TScan Therapeutics, Inc. and PTC Therapeutics, Inc. He is responsible for the strategic direction of these companies and managing daily operations. His role involves working closely with the board of directors to define the company's objectives and ensure its growth. Through his leadership, he contributes to the success of TScan and PTC.
